These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36357795)

  • 41. Postoperative outcome after palliative treatment of malignant pleural effusion.
    Markowiak T; Ried M; Großer C; Hofmann HS; Hillejan L; Hecker E; Semik M; Lesser T; Kugler C; Seifert S; Scheubel R
    Thorac Cancer; 2022 Aug; 13(15):2158-2163. PubMed ID: 35748347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of malignant pleural effusion.
    Chen H; Brahmer J
    Curr Oncol Rep; 2008 Jul; 10(4):287-93. PubMed ID: 18778553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial.
    Dipper A; Sundaralingam A; Hedley E; Tucker E; White P; Bhatnagar R; Moore A; Dobson M; Luengo-Fernandez R; Mills J; Sowden S; Harvey JE; Dobson L; Miller RF; Munavvar M; Rahman N; Maskell N
    BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37253535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
    Goodman A; Davies CW
    Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.
    Yildirim H; Metintas M; Ak G; Erginel S; Alatas F; Kurt E; Metintas S; Ucgun I
    Lung; 2007 Dec; 185(6):349-54. PubMed ID: 17952507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion.
    Beck TN; Deneka AY; Chai L; Kanach C; Johal P; Alvarez NJ; Boumber Y; Golemis EA; Laub GW
    BMC Cancer; 2019 Jun; 19(1):614. PubMed ID: 31234819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis.
    Olden AM; Holloway R
    J Palliat Med; 2010 Jan; 13(1):59-65. PubMed ID: 19839739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Talc pleurodesis for the management of malignant pleural effusions in Japan.
    Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
    Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
    Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
    Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
    Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
    Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Talc pleurodesis in recurrent pleural effusions.
    Jacobi CA; Wenger FA; Schmitz-Rixen T; Müller JM
    Langenbecks Arch Surg; 1998 Apr; 383(2):156-9. PubMed ID: 9641889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
    Walter M; Türler A; Schmitz-Rixen T
    Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis.
    Lending G; El Ghani YA; Kaykov E; Svirsky B; Cohen HI; Altman E
    Indian J Surg Oncol; 2021 Mar; 12(1):54-60. PubMed ID: 33814832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
    Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of recurrent malignant pleural effusion with chemical pleurodesis.
    Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
    Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
    Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
    Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Talc pleurodesis in pleuropulmonary diseases treatment.
    Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
    Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial.
    Haddad FJ; Younes RN; Gross JL; Deheinzelin D
    World J Surg; 2004 Aug; 28(8):749-53; discussion 753-4. PubMed ID: 15457352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
    Olfert JA; Penz ED; Manns BJ; Mishra EK; Davies HE; Miller RF; Luengo-Fernandez R; Gao S; Rahman NM
    Respirology; 2017 May; 22(4):764-770. PubMed ID: 27983774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.